Steffen S Docken

14PUBLICATIONS
48CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersMedical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 27, 2026
A hERG blocker facilitates K+ channel current by promoting pore opening while blocking.

|Aug 27, 2026
Reconciliation of titer differences between SARS-CoV-2 neutralizing antibody assays.

|Jul 28, 2026
The rebound-initiating viral reservoir (RIVR) in SIV/SHIV infection is dominated by plasma virus sequences present at the time of ART initiation.

|Jun 12, 2026
A hERG Blocker Facilitates K+ Channel Current by Agonizing Pore Opening while Blocking.

|Feb 18, 2026
Dissecting the steps in early simian immunodeficiency virus dissemination following mucosal and intravenous infection of rhesus macaques.

Steffen S Docken, Agatha Macairan, Timothy E Schlub

|Aug 14, 2025
Therapeutic CD8+ T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound.

M Betina Pampena, Sadia Samer, Elise G Viox

Pageof 3

Frequent Collaborators

5 joint publications

Miles P Davenport

4 joint publications

Brandon F Keele

3 joint publications

Deborah Cromer

3 joint publications

Colleen E Clancy